The type of found cell is thought to influence the efficiency of
iPS cell differentiation to blood cells, with blood founder cells being best.
Not exact matches
Yamanaka's group and two others followed up earlier this year with firmer evidence that these induced pluripotent stem (
iPS)
cells faithfully mimicked the patterns of gene activity and cellular
differentiation observed in embryonic stem
cells.
Wu, who is also a professor of cardiovascular medicine and of radiology, said, «This study certainly makes us optimistic that
differentiation — into any nonpluripotent
cell type — will render
iPS cells less recognizable to the immune system.
These findings reveal molecular factors that can be used to evaluate the
differentiation potential of different
cell lines, which should expedite the progress of
iPS cells to clinical use.
Another factor that could also contribute to the efficiency of
iPS cell line
differentiation is the method with which the
iPS cells were made.
Indeed, we have obtained a homogenous mesodermal
cell populations derived from human pluripotent stem
cells (hES and
iPS cells), which could represent discreet
differentiation steps.
Human
iPS cell - derived hepatocytes differentiated with our robust
differentiation protocol and cultured using our novel maintenance medium provide an inexhaustible, consistent supply of functional hepatocytes that can be used to advance the understanding of diseases related to dysfunction in liver metabolism, including NAFLD / NASH, type 2 diabetes, and metabolic syndrome.
NeuroStemcell is focused on the identification and systematic comparison of progenitor
cell lines with the most favourable characteristics for mesDA and striatal GABAergic neuronal
differentiation, generated either directly from human embryonic stem (ES)
cells, from Neural Stem (NS)
cells derived from ES
cells or fetal brain, from induced Pluripotent Stem (
iPS)
cells or from in vitro short - term expanded neural progenitors from ventral midbrain grown as neurospheres (VMN, Ventral Midbrain Neurospheres) 4, and perform rigorous and systematic testing of the most prominent candidate
cells in appropriate animals models.
Human
iPS cell - derived hepatocytes differentiated with our robust
differentiation protocol and cultured using a novel maintenance medium provide an inexhaustible, consistent supply of functional hepatocytes that can be used to advance the understanding of diseases related to dysfunction in liver metabolism, including NAFLD / NASH, type 2 diabetes, and metabolic syndrome.
«This collaboration combines Dr. Yamanaka's human
iPS cells and Novocell's hES
cell differentiation and encapsulation technologies to explore the creation of next generation diabetes
cell therapies,» said Emmanuel Baetge, Chief Scientific Officer of Novocell, Inc..
(c) The ratio of beating EBs in directed
differentiation of
iPS cells of line 11.1 into cardiomyocytes was shown.
In this study, we analyzed three different cultures of neural
cells carrying trisomy of chromosome 21, which were generated by directed
differentiation from induced pluripotent stem
cells (
iPS cells).
Interestingly,
cells from both
iPS cell lines expressed early cardiac
differentiation markers and transcription factors, implicating that there could be a lack in functional cardiomyocyte maturation in line 4.1.
The early cardiac markers and transcription factors (Gata4, Mef2c, Hind I, Nkx2 - 5 and beta - Mhc) were examined in
iPS cell lines 11.1 and 4.1 during the cardiac
differentiation process (
differentiation day 0, day 3, day 6 and day 9).
(C) Directed
differentiation of
iPS cells of line 11.1 into neural lineages.
For monolayer
differentiation, confluent
iPS cells were cultured in the HFF culture medium without any growth factors.
A team led by Donald Ingber, Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and Founding Director of Harvard's Wyss Institute of Biologically Inspired Engineering, now reports a solution to this challenge in Nature Biomedical Engineering, which enables the
differentiation of human induced pluripotent stem (
iPS)
cells into mature podocytes with more than 90 percent efficiency.
Signaling pathways / factors regulating and / or initiating ESC /
iPS cells pluripotency and
differentiation
Here we report the
differentiation of human
iPS cells into RPE.
The successful
differentiation of
iPS cells into RPE represents a significant advance in the search for a potential
cell source for the treatment of human neural retinal diseases.
Through genome - wide profiling we find that 5 - 46 % of the variation in different
iPS cell phenotypes, including
differentiation capacity and cellular morphology, arises from differences between individuals.
iPS (IMR90)-3
cells readily differentiate into RPE
cells and the
differentiation protocol used in this paper is a highly efficient method of producing multiple confluent flasks of highly enriched pigmented
cells.
iPS - RPE also down - regulate the embryonic transcription factors originally used to induce pluripotency from the somatic
cell [18], suggesting
differentiation away from the initial
iPS phenotype.
378/11: 15 Smith - Lemli - Opitz Syndrome
iPS cells demonstrate abnormal neuronal
differentiation due to 7 - dehydrocholesterol impairment of Wnt / β - Catenin signaling.
By developing a simple chemically defined culture system permitting efficient
differentiation of numerous human
iPS cell lines toward
cells of a mature hepatic state, we now demonstrate the possibility of modeling groups of diseases of non-neuronal origin whose phenotypes are a consequence of complex protein dysregulation within adult
cells.